ATE360071T1 - Rezeptor für ein toxin aus bacillus anthracis - Google Patents

Rezeptor für ein toxin aus bacillus anthracis

Info

Publication number
ATE360071T1
ATE360071T1 AT01986969T AT01986969T ATE360071T1 AT E360071 T1 ATE360071 T1 AT E360071T1 AT 01986969 T AT01986969 T AT 01986969T AT 01986969 T AT01986969 T AT 01986969T AT E360071 T1 ATE360071 T1 AT E360071T1
Authority
AT
Austria
Prior art keywords
anthrax toxin
polypeptides
present
receptor
polynucleotides
Prior art date
Application number
AT01986969T
Other languages
English (en)
Inventor
John A T Young
Kenneth A Bradley
Robert J Collier
Jeremy S Mogridge
Original Assignee
Wisconsin Alumni Res Found
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found, Harvard College filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE360071T1 publication Critical patent/ATE360071T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
AT01986969T 2000-12-05 2001-10-03 Rezeptor für ein toxin aus bacillus anthracis ATE360071T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25148100P 2000-12-05 2000-12-05

Publications (1)

Publication Number Publication Date
ATE360071T1 true ATE360071T1 (de) 2007-05-15

Family

ID=22952145

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01986969T ATE360071T1 (de) 2000-12-05 2001-10-03 Rezeptor für ein toxin aus bacillus anthracis

Country Status (6)

Country Link
US (4) US7074913B2 (de)
EP (1) EP1395657B1 (de)
AT (1) ATE360071T1 (de)
AU (1) AU2002239229A1 (de)
DE (1) DE60128008T2 (de)
WO (1) WO2002046228A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455673B1 (en) * 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
US6808709B1 (en) * 1994-12-30 2004-10-26 The Regents Of The University Of California Immunoglobulins containing protection proteins and their use
US20020168367A1 (en) * 2000-04-28 2002-11-14 Planet Biotechnology Incorporated Novel immunoadhesins for treating and preventing viral and bacterial diseases
US20060015969A1 (en) * 2000-04-28 2006-01-19 Planet Biotechnology, Inc. Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases
CN101643512A (zh) * 2000-04-28 2010-02-10 行星生物技术有限公司 预防鼻病毒感染的新型免疫粘附素
AU2001283062A1 (en) * 2000-08-02 2002-02-13 The Johns Hopkins University Endothelial cell expression patterns
ATE360071T1 (de) * 2000-12-05 2007-05-15 Wisconsin Alumni Res Found Rezeptor für ein toxin aus bacillus anthracis
US20070118934A1 (en) * 2001-10-26 2007-05-24 Planet Biotechnology, Inc. Chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax
US20030144193A1 (en) * 2001-12-20 2003-07-31 Rottman James B. TANGO 197 and TANGO 216 compositions and methods
US7601351B1 (en) 2002-06-26 2009-10-13 Human Genome Sciences, Inc. Antibodies against protective antigen
WO2004052277A2 (en) * 2002-12-05 2004-06-24 Wisconsin Alumni Research Foundation Anthrax antitoxins
GB0423974D0 (en) * 2004-10-28 2004-12-01 Ares Trading Sa Proteins
WO2006089114A2 (en) * 2005-02-17 2006-08-24 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for treating an anthrax toxin mediated condition
ITRM20060337A1 (it) * 2006-06-27 2007-12-28 Biosoot Srl Gene tem8 (tumor endotelial marker 8) e sue forme di espressione ed usi diagnostici e terapeutici
US20110117121A1 (en) * 2006-10-27 2011-05-19 James Dao Compositions for treatment and inhibition of pain
TW201425333A (zh) * 2007-04-11 2014-07-01 Oncotherapy Science Inc 腫瘤血管內皮標誌８胜肽及包含此胜肽之疫苗
US7935345B2 (en) 2007-05-21 2011-05-03 Children's Hospital & Research Center At Oakland Monoclonal antibodies that specifically bind to and neutralize bacillus anthracis toxin, compositions, and methods of use
EP2721071A4 (de) * 2011-06-14 2015-01-21 Us Health Tem8-antikörper, konjugate davon und ihre verwendung
WO2012172495A1 (en) * 2011-06-14 2012-12-20 Novartis Ag Compositions and methods for antibodies targeting tem8
EP3054987B1 (de) 2013-10-11 2019-10-09 The United States of America, represented by the Secretary, Department of Health and Human Services Tem-8-antikörper und deren verwendung
US10717927B2 (en) 2016-07-14 2020-07-21 Samsung Electronics Co., Ltd. Indium-based quantum dots and production methods thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604201A (en) * 1993-01-08 1997-02-18 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non-Profit Organization Methods and reagents for inhibiting furin endoprotease
US5677274A (en) * 1993-02-12 1997-10-14 The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services Anthrax toxin fusion proteins and related methods
US5591631A (en) * 1993-02-12 1997-01-07 The United States Of America As Represented By The Department Of Health And Human Services Anthrax toxin fusion proteins, nucleic acid encoding same
US20030202989A1 (en) * 1995-12-13 2003-10-30 R. John Collier Use of toxin peptides and/or affinity handles for delivering compounds into cells
US6592872B1 (en) * 1996-09-17 2003-07-15 The United States Of America As Represented By The Department Of Health And Human Services Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein
WO2001034626A1 (en) * 1999-11-05 2001-05-17 Human Genome Sciences, Inc. 28 human secreted proteins
US7411051B2 (en) * 1997-03-07 2008-08-12 Human Genome Sciences, Inc. Antibodies to HDPPA04 polypeptide
US7368531B2 (en) * 1997-03-07 2008-05-06 Human Genome Sciences, Inc. Human secreted proteins
EP1066401A2 (de) * 1998-04-01 2001-01-10 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Anthrax-tödlich-faktor ist eine mapk-kinase-protease
US7175679B2 (en) * 2001-03-29 2007-02-13 Biotempt B.V. Oligopeptide treatment of NF-κB mediated inflammation
WO2000039284A1 (en) 1998-12-30 2000-07-06 Millennium Pharmaceuticals, Inc. Secreted proteins and nucleic acids encoding them
US6329156B1 (en) * 1999-03-22 2001-12-11 The Regents Of The University Of California Method for screening inhibitors of the toxicity of Bacillus anthracis
AU784131B2 (en) * 1999-12-22 2006-02-09 Darrell R. Galloway Methods for protecting against lethal infection with bacillus anthracis
EP1242443A4 (de) * 1999-12-23 2005-06-22 Nuvelo Inc Neue nukleinsäuren und polypeptide
US6569662B1 (en) * 2000-01-21 2003-05-27 Hyseq, Inc. Nucleic acids and polypeptides
EP1803730A1 (de) * 2000-04-12 2007-07-04 Human Genome Sciences, Inc. Albuminfusionsproteine
MXPA02010826A (es) * 2000-05-04 2006-03-09 Harvard College Compuestos y metodos para el tratamiento y la prevencion de infeccion bacteriana.
AU2001283062A1 (en) * 2000-08-02 2002-02-13 The Johns Hopkins University Endothelial cell expression patterns
ATE360071T1 (de) * 2000-12-05 2007-05-15 Wisconsin Alumni Res Found Rezeptor für ein toxin aus bacillus anthracis
JP2004533825A (ja) * 2001-04-11 2004-11-11 ザ ジョンズ ホプキンス ユニバーシティ 内皮細胞発現パターンの評価法
US20060084794A1 (en) * 2001-04-12 2006-04-20 Human Genome Sciences, Inc. Albumin fusion proteins
US20030108556A1 (en) * 2001-06-08 2003-06-12 Mekalanos John J. Therapeutic uses of polyvalent compositions in infectious diseases
US7176278B2 (en) * 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
US20070118934A1 (en) * 2001-10-26 2007-05-24 Planet Biotechnology, Inc. Chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax
GB0126266D0 (en) * 2001-11-01 2002-01-02 Microbiological Res Authority Anthrax antigenic compositions
AU2002357747A1 (en) * 2001-12-10 2003-06-23 Millennium Pharmaceuticals Inc. Novel genes encoding colon cancer antigens
US20040258699A1 (en) * 2002-02-11 2004-12-23 Bowdish Katherine S. Immunotherapeutics for biodefense
WO2004052277A2 (en) * 2002-12-05 2004-06-24 Wisconsin Alumni Research Foundation Anthrax antitoxins
AU2003900747A0 (en) * 2003-02-18 2003-03-06 Garvan Institute Of Medical Research Diagnosis and treatment of pancreatic cancer
WO2005005598A2 (en) * 2003-04-11 2005-01-20 New York University B. anthracis luxs and furanone inhibition of a1-2 quorum sensing
MXPA05012571A (es) * 2003-05-21 2006-02-08 Medarex Inc Anticuerpos monoclonales humanos contra el antigeno protector de bacillus anthracis.
US20060246079A1 (en) * 2003-11-14 2006-11-02 Morrow Phillip R Neutralizing human antibodies to anthrax toxin
WO2005081749A2 (en) * 2004-01-23 2005-09-09 Avanir Pharmaceuticals, Inc. Neutralizing human antibodies to anthraxtoxin
CA2560759A1 (en) * 2004-03-03 2005-12-22 Iq Corporation Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof
US7588912B2 (en) * 2004-10-12 2009-09-15 Regents Of The University Of California Compositions and methods for preventing and treating anthrax diseases

Also Published As

Publication number Publication date
WO2002046228A2 (en) 2002-06-13
US20060110801A1 (en) 2006-05-25
US20060083746A1 (en) 2006-04-20
EP1395657A2 (de) 2004-03-10
US7074913B2 (en) 2006-07-11
DE60128008T2 (de) 2008-01-10
US20070117159A1 (en) 2007-05-24
US7435418B2 (en) 2008-10-14
EP1395657B1 (de) 2007-04-18
AU2002239229A1 (en) 2002-06-18
US20050196407A1 (en) 2005-09-08
WO2002046228A3 (en) 2003-12-24
DE60128008D1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
ATE360071T1 (de) Rezeptor für ein toxin aus bacillus anthracis
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
ATE454463T1 (de) Überexpression von extremozymgenen in pseudomonas und nahe verwandte bakterien
DK1836299T4 (da) Polypeptider, der har cellobiohydrolaseaktivitet, og polynukleotider, der koder for disse
ATE337011T1 (de) Modifizierte psma-liganden und deren verwendung
PT3184545T (pt) Agentes antagonísticos de ligação seletiva da proteína de ligação da osteoprotegerina
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
DK1131444T3 (da) Polypeptider med lysophospholipase aktivitet og nucleinsyre som koder for disse
DE60138715D1 (de) Tnf-rezeptor-ähnliche moleküle und deren anwendungen
DE60109430D1 (de) An entzündlichen darmerkrankungen beteiligte gene und deren verwendung
NZ504669A (en) Virulence-associated nucleic acid sequences and uses in identification of anti-virulence agents
DK1007666T3 (da) Neurturinreceptor
DE69920487D1 (de) Tau als marker für frühe schäden des zentralen nervensystems
ATE520025T1 (de) Test für morbus-parkinson-therapeutika
DE69942575D1 (de) Nukleinsäuremolekül, die für die alpha-kettedes pferde-fc-epsilon-rezeptors kodieren, korrespondierende proteine und ihre verwendungen
WO2004044165A3 (en) Lipid-associated proteins
GB0509611D0 (en) Method and device for imaging a sample
MXPA05006769A (es) El grupo genetico incluido en biosintesis de safracin y sus usos para ingenieria genetica.
WO2001042285A3 (en) Extracellular matrix and cell adhesion proteins as well as genes encoding them
MXPA03010728A (es) Moleculas de proteina-2 relacionadas con b7 y uso de las mismas.
WO2005051985A3 (en) Methods for purifying pertussis toxin and peptides useful therefor
MX2010004097A (es) Complejos de los dominios de trpc y sestd1 y metodos y usos que implican los mismos.
EP0891984A3 (de) Nukleinsäure kodierend für streptococcus pneumoniae response-regulator
EP0885901A3 (de) Nukleinsäure kodierend für Streptococcus pneumoniae Response-Regulator
WO2000040607A3 (en) Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties